Recruitment
Recruitment Target: 60 in total (8 participants in Phase I and 52 participants in Phase II)
Recruitment Duration: 24 months
Trial Duration: Participants will be followed up for 2 years from when they receive their first dose of ITOP1/Placebo (with possibility to extend with the optional survival follow-up period)
